| Long name: |
TDGF1 Antibody |
| Antigen: |
TDGF1 |
| Synonim names: |
CR, CRGF, CRIPTO, Cripto-1 , TDGF1 |
| Other names: |
CRGF, Cripto-1 growth factor, Epidermal growth factor-like cripto protein CR1, Teratocarcinoma-derived growth factor 1, cripto-1 growth factor, epidermal growth factor-like cripto protein CR1, teratocarcinoma-derived growth factor 1, teratocarcinoma-derived growth factor 1, teratocarcinoma-derived growth factor 1 isoform 2 |
| Gene name: |
TDGF1, TDGF1 |
| Gene synonims: |
CR, CRGF, CRGF, CRIPTO, CRIPTO, TDGF1, TDGF1 |
| Category: |
Antibodies |
| Clone: |
Not applicable to Polyclonal Antibodies |
| Reacts with: |
Mouse (Mus musculus), Rat (Rattus norvegicus), Human (Homo sapiens) |
| Specificity: |
TDGF1, This is an antibody designed to detect TDGF1 |
| Purification method: |
Antigen Affinity method, Caprylic Acid Ammonium Sulfate Precipitation, etc, The most common purification methods used in the antibody production are Affinity Chromatography |
| Concentration: |
Enquire us for detailed information on the concentration of this antibody |
| Storage, shipping and handling: |
Avoid freeze / thaw cycles, Store at -20 degree C or -80 degree C |
| Applications: |
Immunohistochemistry (IHC), Western Blot (WB) |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by MBS Polyclonals they should be stored frozen at - 24° |
| Gene target: |
TDGF1 |
| Short name: |
Anti- TDGF1 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
Antibody to teratocarcinoma-derived growth factor 1 (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
CR and CRGF and CRIPTO, TDGF1 and IDBG-409017 and ENSG00000241186 and 6997, Tdgf1 and IDBG-202568 and ENSMUSG00000032494 and 21667, embryo and biological process this GO :0009790 and embryo development and biological process this GO :0009948 and anterior/posterior axis specification and biological process this GO :0009966 and regulation of signal transduction and biological process this GO :0009986 and cell surface and cellular component this GO :0010595 and positive regulation of endothelial cell migration and biological process this GO :0016324 and apical plasma membrane and cellular component this GO :0018105 and peptidyl-serine phosphorylation and biological process this GO :0019897 and extrinsic component of plasma membrane and cellular component this GO :0030154 and cell differentiation and biological process this GO :0030334 and regulation of cell migration and biological process this GO :0030335 and positive regulation of cell migration and biological process this GO :0030509 and BMP signaling pathway and biological process this GO :0030512 and negative regulation of transforming growth factor beta receptor signaling pathway and biological process this GO :0030879 and mammary gland development and biological process this GO :0031225 and anchored component of membrane and cellular component this GO :0035729 and cellular response to hepatocyte growth factor stimulus and biological process this GO :0043066 and negative regulation of apoptotic process and biological process this GO :0044344 and cellular response to fibroblast growth factor stimulus and biological process this GO :0045121 and membrane raft and cellular component this GO :0045944 and positive regulation of transcription from RNA polymerase II promoter and biological process this GO :0048146 and positive regulation of fibroblast proliferation and biological process this GO :0048471 and perinuclear region of cytoplasm and cellular component this GO :0050731 and positive regulation of peptidyl-tyrosine phosphorylation and biological process this GO :0055007 and cardiac muscle cell differentiation and biological process this GO :0060070 and canonical Wnt signaling pathway and biological process this GO :0071346 and cellular response to interferon-gamma and biological process this GO :0071354 and cellular response to interleukin-6 and biological process this GO :0071356 and cellular response to tumor necrosis factor and biological process this GO :0071364 and cellular response to epidermal growth factor stimulus and biological process, growth factor activity, nuclei, this GO :0000187 and activation of MAPK activity and biological process this GO :0001570 and vasculogenesis and biological process this GO :0001701 and in utero embryonic development and biological process this GO :0001763 and morphogenesis of a branching structure and biological process this GO :0001954 and positive regulation of cell-matrix adhesion and biological process this GO :0002042 and cell migration involved in sprouting angiogenesis and biological process this GO :0005102 and receptor binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005615 and extracellular space and cellular component this GO :0005634 and nucleus and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005794 and this GO lgi apparatus and cellular component this GO :0007369 and gastrulation and biological process this GO :0007507 and heart development and biological process this GO :0008083 and growth factor activity and molecular function this GO :0008284 and positive regulation of cell proliferation and biological process this GO :0008595 and anterior/posterior axis specification, this GO :0005102 : receptor binding, this GO :0005102 : receptor binding and also this GO :0005515 : protein binding and also this GO :0008083 : growth factor activity, this GO :0005515 : protein binding, this GO :0008083 : growth factor activity, teratocarcinoma-derived growth factor 1 |
| Identity: |
11701 |
| Gene: |
TDGF1 |
More about : TDGF1 |
| Long gene name: |
teratocarcinoma-derived growth factor 1 |
| Synonyms: |
CRIPTO CR Cripto-1 |
| Locus: |
3p21, 31 |
| Discovery year: |
1990-08-02 |
| GenBank acession: |
M96955 |
| Entrez gene record: |
6997 |
| Pubmed identfication: |
1882841 10393436 |
| RefSeq identity: |
NM_003212 |